| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 74.135 | 79.135 | 79.661 | 93.393 | 88.104 | 114.733 | 146.215 | 179.241 | 223.333 | 256.210 |
| Total Income - EUR | 74.136 | 79.136 | 79.662 | 93.402 | 88.104 | 114.734 | 146.216 | 179.244 | 223.560 | 257.526 |
| Total Expenses - EUR | 69.544 | 74.406 | 74.806 | 88.146 | 88.297 | 110.652 | 134.961 | 166.531 | 204.932 | 243.865 |
| Gross Profit/Loss - EUR | 4.592 | 4.730 | 4.856 | 5.256 | -193 | 4.082 | 11.255 | 12.713 | 18.629 | 13.662 |
| Net Profit/Loss - EUR | 3.847 | 3.927 | 4.039 | 4.300 | -1.086 | 3.217 | 9.819 | 11.037 | 16.721 | 11.758 |
| Employees | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 3 |
Check the financial reports for the company - Farmaconstec Surveyor Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 18.009 | 14.578 | 15.115 | 17.271 | 14.286 | 18.663 | 25.630 | 41.673 | 68.699 | 51.557 |
| Inventories | 4.691 | 3.920 | 3.936 | 4.574 | 4.584 | 7.172 | 9.885 | 10.814 | 13.915 | 20.697 |
| Receivables | 5.516 | 2.663 | 6.683 | 8.018 | 5.869 | 7.251 | 10.162 | 12.672 | 17.496 | 10.884 |
| Cash | 7.803 | 7.996 | 4.496 | 4.679 | 3.832 | 4.240 | 5.584 | 18.187 | 37.288 | 19.975 |
| Shareholders Funds | 2.464 | 3.972 | 4.083 | 4.343 | -1.035 | 2.201 | 9.867 | 11.086 | 26.675 | 11.806 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.546 | 10.607 | 11.032 | 12.928 | 15.321 | 16.462 | 15.763 | 30.587 | 42.024 | 39.750 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaconstec Surveyor Srl